Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 1234 Next »
Viewing Page 1 of 4 | Showing Results 1 - 5 of 16

ONC TheraSphere-A Humanitarian Device Exemption Treatment Protocol of TheraSphere� For Treatment of Unresectable Hepatocellular Carcinoma

The purpose of this protocol is to provide TheraSphere treatment for patients with liver cancer who cannot be treated by surgery. The effect on the...

Chakri Inampudi, M.D.
  • Alaska Research
  • Providence Alaska Medical Center

A Phase II Study of Weekly Abraxane for Patients With Advanced NSCLC With EGFR Mutations or With Durable Response to an EGFR Tyrosine Kinase Inhibitor Following Front Line Therapy With EGFR Tyrosine Kinase Inhibitors

This research study examines the use of Abraxane (paclitaxel albumin-stabilized nanoparticle formulation) in patients with lung cancer. Abraxane is...

Jeanne Anderson MD
  • Alaska Research
  • Katmai Oncology Group

Phase II Trial of Metronomic Eribulin (Halaven) in Pretreated Metastatic Breast Cancer (MBC)

This phase II trial studies how well eribulin mesylate works in treating patients with previously treated breast cancer that has spread to other...

Jeanne Anderson MD
  • Alaska Research
  • Katmai Oncology Group

ONC AALL08B1-Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health...

Brenda Wittman, M.D.
  • Alaska Research
  • Providence Alaska Medical Center

A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum

This randomized phase III trial is studying how well combination chemotherapy works in treating young patients with newly diagnosed high-risk acute...

Brenda Wittman, M.D.
  • Alaska Research
  • Providence Alaska Medical Center
« Previous 1234 Next »
Viewing Page 1 of 4 | Showing Results 1 - 5 of 16